Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Grepafloxacin: microbiological properties.

Marriott MS.

Clin Microbiol Infect. 1998 Mar;4 Suppl 1:S9-S14.

2.

Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D.

Antimicrob Agents Chemother. 1998 Nov;42(11):2863-9.

3.

Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts.

Domínguez JM, Kelly VA, Kinsman OS, Marriott MS, Gómez de las Heras F, Martín JJ.

Antimicrob Agents Chemother. 1998 Sep;42(9):2274-8.

4.

The dog did nothing in the night-time.

Marriott MS.

Nature. 1997 May 8;387(6629):119. No abstract available.

PMID:
9144272
5.

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function.

Du Bois SK, Marriott MS, Amyes SG.

J Antimicrob Chemother. 1995 Jan;35(1):7-22. Review.

PMID:
7768784
6.
7.

Plasmid mediated ceftazidime resistance identified in a strain of Serratia marcescens isolated in Belgium.

Payne DJ, Marriott MS, Amyes SG.

J Antimicrob Chemother. 1991 May;27(5):689-93. No abstract available.

PMID:
1885428
8.

No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis carinii.

Jackson HC, Colthurst D, Hancock V, Marriott MS, Tuite MF.

J Infect Dis. 1991 Mar;163(3):675-7.

PMID:
1995744
9.

Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system).

Payne DJ, Hood J, Marriott MS, Amyes SG.

FEMS Microbiol Lett. 1990 Jun 1;57(3):195-200.

PMID:
2210330
10.

Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.

Payne DJ, Marriott MS, Amyes SG.

J Med Microbiol. 1990 Jun;32(2):131-4.

PMID:
2192063
11.

Discovery of fluconazole, a novel antifungal agent.

Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ.

Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S267-71. Review.

PMID:
2184503
12.

Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.

Payne DJ, Marriott MS, Amyes SG.

J Antimicrob Chemother. 1989 Aug;24(2):103-10.

PMID:
2676935
13.

TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.

Payne DJ, Marriott MS, Amyes SG.

FEMS Microbiol Lett. 1989 May;50(1-2):97-100.

PMID:
2661324
14.

1-(3-cyano-2,3-dideoxy-beta-D-erythro-pentofuranosyl)thymine (cyanothymidine): synthesis and antiviral evaluation against human immunodeficiency virus.

Greengrass CW, Hoople DW, Street SD, Hamilton F, Marriott MS, Bordner J, Dalgleish AG, Mitsuya H, Broder S.

J Med Chem. 1989 Mar;32(3):618-22.

PMID:
2918509
15.

In vitro potency and in vivo activity of azoles.

Troke PF, Marriott MS, Richardson K, Tarbit MH.

Ann N Y Acad Sci. 1988;544:284-93. No abstract available.

PMID:
3063173
16.

Design and evaluation of a systemically active agent, fluconazole.

Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ.

Ann N Y Acad Sci. 1988;544:4-11. No abstract available.

PMID:
2850752
17.

Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.

Troke PF, Andrews RJ, Marriott MS, Richardson K.

J Antimicrob Chemother. 1987 May;19(5):663-70.

PMID:
3038824
18.

An alteration in tubulin expression detected in SV40 transformed 3T3 cells.

Raxworthy MJ, Shaw JR, Marriott MS.

Cell Biol Int Rep. 1986 Jul;10(7):555-63.

PMID:
3015424
19.

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

Troke PF, Andrews RJ, Brammer KW, Marriott MS, Richardson K.

Antimicrob Agents Chemother. 1985 Dec;28(6):815-8.

20.

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

Richardson K, Brammer KW, Marriott MS, Troke PF.

Antimicrob Agents Chemother. 1985 May;27(5):832-5.

21.

Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.

Marriott MS, Baird JR, Brammer KW, Faulkner JK, Halliwell G, Jevons S, Tarbit MH.

Dermatologica. 1983;166 Suppl 1:1-7.

PMID:
6884559
22.

Tioconazole, a new broad-spectrum antifungal agent: preclinical studies related to vaginal candidiasis.

Marriott MS, Brammer KW, Faccini J, Faulkner JK, Jevons S, Monro AM, Nachbaur J, Perraud J, Tarbit MH.

Gynakol Rundsch. 1983;23 Suppl 1:1-11. No abstract available.

PMID:
6683696
23.

Inhibition of sterol C14 demethylation by imidazole-containing antifungals.

Pye GW, Marriott MS.

Sabouraudia. 1982 Dec;20(4):325-9. No abstract available.

PMID:
6760419
24.
25.

Mannan-protein location and biosynthesis in plasma membranes from the yeast form of Candida albicans.

Marriott MS.

J Gen Microbiol. 1977 Nov;103(1):51-9. No abstract available.

PMID:
338863
26.

Growth characteristics and polyene sensitivity of a fatty acid auxotroph of Candida albicans.

Koh TY, Marriott MS, Taylor J, Gale EF.

J Gen Microbiol. 1977 Sep;102(1):105-10.

PMID:
335019
27.
28.

Supplemental Content

Loading ...
Support Center